.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Ovis operated as a single-category brand in May 2026, with Capsules accounting for 100.0% of sales and posting a year-over-year decline of 41.3% alongside a month-over-month drop of 19.0%; average price rose 7.8% while sales fell, indicating volume contraction within the Capsules mix. In Alberta, Ovis held rank 9 in Capsules during May 2026, and the brand’s average price of $15.81 coincided with a 24‑month sales decline of 60.9%, pointing to a narrowing consumer base concentrated in one format. The pattern implies that a single-format strategy is amplifying downside from demand softness, with price firmness not offsetting volume losses.
With Capsules at 100.0% share and rank 9 in Alberta, the May 2026 mix constrains Ovis’s ability to reallocate toward faster-moving segments when Capsules contract by 41.3% YoY and 19.0% MoM. The 7.8% pricing lift amid double-digit volume pressure indicates that elasticity is binding and that trading-up is insufficient to stabilize rank or share. This implies Ovis’s positioning is increasingly defined by a higher-price Capsule niche where incremental price is eroding reach faster than it preserves revenue, suggesting that category breadth and pack-size or dose innovation would be required to arrest the 60.9% 24‑month slide.
Competitive Landscape
Ovis sits at #9 in AB Capsules in May 2026, unchanged from #9 year over year, after edging up from #10 three months ago and still two spots below its peak of #7 reached in April 2025; in contrast, Tweed holds #1 with a -8.47% YoY sales change while Simply Bare moved up from #8 to #5 on +13.63% YoY growth, indicating that flat rank amid upward and downward competitor shifts points to Ovis maintaining share rather than expanding it.
Notable Products
CBD Softgels 30-Pack (1500mg CBD) posted the steepest decline at -63.2% MoM while holding a mid-pack position at rank 4, and THC Softgel 30-Pack (300mg) also contracted -55.4% MoM from rank 4, indicating acute pressure on larger-count or high-CBD formats. THC Softgel 15-Pack (150mg) retained rank 1 despite a -11.9% MoM dip, whereas the adjacent CBG/CBD/THC 1:1:1 Softgels 15-Pack (75mg CBG, 75mg CBD, 75mg THC) in rank 2 inched up +4.0% MoM, and Blue THC Softgel 50-Pack (125mg) at rank 3 gained +2.7% MoM, creating a split where top-three THC-led SKUs are steadier than CBD-heavy offerings. With all top-10 items concentrated in Capsules and four of the top five anchored by THC or multi-cannabinoid mixes, the mix implies Ovis is pivoting demand toward smaller-count, THC-forward capsules while de-emphasizing pure CBD inventory even as the category remains led by a single flagship SKU.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
